Apixaban vs Durvalumab

## Apixaban vs Durvalumab: Overview

This comparison examines the pharmacological differences between **Apixaban** and **Durvalumab**.

## Mechanism of Action

**Apixaban**: Direct Factor Xa inhibitor.

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

## Pharmacokinetics

**Half-life**: Apixaban — 12 hours; Durvalumab — 17 days.

## Chemical Properties

**Molecular Formula**: Apixaban — C25H25N5O4; Durvalumab — N/A.

**Molecular Weight**: Apixaban — 459.4970 g/mol; Durvalumab — N/A.

**Type**: Apixaban — Small molecule; Durvalumab — Antibody.